These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK. Villa-Moruzzi E Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099 [TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling. Bhatt AB; Patel S; Matossian MD; Ucar DA; Miele L; Burow ME; Flaherty PT; Cavanaugh JE Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572742 [TBL] [Abstract][Full Text] [Related]
8. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. Sawhney RS; Liu W; Brattain MG J Cell Physiol; 2009 Apr; 219(1):152-61. PubMed ID: 19089993 [TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 engineering of ERK5 identifies its FAK/PYK2 dependent role in adhesion-mediated cell survival. Ali M; Mutahir Z; Riaz A Biochem Biophys Res Commun; 2019 May; 513(1):179-185. PubMed ID: 30952431 [TBL] [Abstract][Full Text] [Related]
10. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359 [TBL] [Abstract][Full Text] [Related]
11. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis. Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055 [TBL] [Abstract][Full Text] [Related]
12. Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway. Sun X; Zhang T; Deng Q; Zhou Q; Sun X; Li E; Yu D; Zhong C Mol Cells; 2018 Mar; 41(3):188-197. PubMed ID: 29463068 [TBL] [Abstract][Full Text] [Related]
13. Targeting of FAK Ser910 by ERK5 and PP1delta in non-stimulated and phorbol ester-stimulated cells. Villa-Moruzzi E Biochem J; 2007 Nov; 408(1):7-18. PubMed ID: 17692050 [TBL] [Abstract][Full Text] [Related]
14. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma. Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878 [TBL] [Abstract][Full Text] [Related]
15. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. Simões AE; Pereira DM; Gomes SE; Brito H; Carvalho T; French A; Castro RE; Steer CJ; Thibodeau SN; Rodrigues CM; Borralho PM Cell Death Dis; 2015 Apr; 6(4):e1718. PubMed ID: 25855966 [TBL] [Abstract][Full Text] [Related]
16. ERK5 signalling in prostate cancer promotes an invasive phenotype. Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739 [TBL] [Abstract][Full Text] [Related]
18. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways. Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228 [TBL] [Abstract][Full Text] [Related]
19. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Lin TY; Hsu HY Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741 [TBL] [Abstract][Full Text] [Related]
20. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Fulford L; Milewski D; Ustiyan V; Ravishankar N; Cai Y; Le T; Masineni S; Kasper S; Aronow B; Kalinichenko VV; Kalin TV Sci Signal; 2016 May; 9(427):ra48. PubMed ID: 27165781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]